Int J Health Policy Manag. 2023;12: 7724 | Published on: 2023 Sep 20. doi: 10.34172/ijhpm.2023.7724

PMID: 38618801 PMCID: PMC10590231

Original Article

Impact of China’s National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin

Boya Zhao ^1,2 , Jing Wu ^1,2 *

Cited by CrossRef:

1- Zhao B, Wu J, Feng X. Testing the unintended cost effects of health policies for generic substitutions: the case of China’s National Volume-Based Procurement (NVBP) policy. 2025;40(2):194 [Crossref]

2- Li A, Li G, Han D, Fu M, Chang J. A comparative study of hospitalization costs of TKA inpatients before and after National Volume-based Procurement in Guangdong, China: an interrupted time-series analysis. Front Public Health. 2025;12 [Crossref]

3- Chen M, Yu Y, Yu B, Cao Y, Lou Y, Ma Y. Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy: a cost-utility analysis from the perspective of Chinese healthcare system. Front Neurol. 2025;16 [Crossref]

Submit Your Paper Archive